Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Nasdaq Pharmaceuticals ETF (FTXH)

Nasdaq Pharmaceuticals ETF (FTXH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 44,837,500
  • Shares Outstanding, K 1,700
  • 60-Month Beta 0.76
Trade FTXH with:
  • Price/Earnings ttm 16.97
  • Annual Dividend & Yield 0.24 (0.89%)
  • Most Recent Dividend 0.038 on 06/24/22
  • Management Fee 0.60%
  • Sectors:

    ETFs - Large Cap

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 16.80%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 69.74% on 02/14/22
  • IV Low 0.00% on 08/11/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 5
  • Open Int (30-Day) 5

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.00 +1.44%
on 08/01/22
27.04 -2.46%
on 07/12/22
-0.38 (-1.40%)
since 07/11/22
3-Month
24.49 +7.72%
on 06/16/22
27.27 -3.28%
on 07/08/22
+1.11 (+4.39%)
since 05/11/22
52-Week
23.92 +10.26%
on 02/24/22
28.44 -7.26%
on 04/11/22
-0.01 (-0.03%)
since 08/11/21

Most Recent Stories

More News
3 Health Care ETFs You'll Want to Own When the Market Recovers

Last month, the S&P 500 witnessed its best month in two years after suffering its worst-first half since 1970. However, the multi-decade high inflation and the GDP decline for two consecutive quarters...

FTXH : 26.38 (-0.99%)
PPH : 75.83 (-0.72%)
VHT : 245.91 (-0.69%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.67 (-0.10%)
FEMB : 27.16 (+0.07%)
FMB : 51.65 (-0.36%)
FMHI : 49.17 (+0.04%)
RFDI : 57.28 (-0.44%)
RFEM : 55.57 (-0.13%)
RFEU : 60.64 (-0.15%)
FCVT : 34.26 (+0.06%)
FTSL : 46.12 (-0.13%)
HISF : 46.14 (-0.21%)
HYLS : 42.31 (-0.05%)
LMBS : 48.44 (-0.12%)
Pharma ETFs in Focus Post Q1 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

PJP : 75.24 (-1.16%)
IHE : 188.34 (-1.57%)
XPH : 43.70 (-1.53%)
PPH : 75.83 (-0.72%)
FTXH : 26.38 (-0.99%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.67 (-0.10%)
FEMB : 27.16 (+0.07%)
FMB : 51.65 (-0.36%)
FMHI : 49.17 (+0.04%)
RFDI : 57.28 (-0.44%)
RFEU : 60.64 (-0.15%)
FCVT : 34.26 (+0.06%)
FTSL : 46.12 (-0.13%)
HISF : 46.14 (-0.21%)
HYLS : 42.31 (-0.05%)
LMBS : 48.44 (-0.12%)
FTHI : 21.37 (+0.50%)
Analysts Anticipate 25% Upside For The Holdings of FTXH

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

FTXH : 26.38 (-0.99%)
Solid Q4 Earnings Fail to Impress Pharma ETFs

Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.

PJP : 75.24 (-1.16%)
IHE : 188.34 (-1.57%)
XPH : 43.70 (-1.53%)
PPH : 75.83 (-0.72%)
FTXH : 26.38 (-0.99%)
Surprising Analyst 12-Month Target For FTXH

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

FTXH : 26.38 (-0.99%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.67 (-0.10%)
FEMB : 27.16 (+0.07%)
FMB : 51.65 (-0.36%)
FMHI : 49.17 (+0.04%)
RFDI : 57.28 (-0.44%)
RFEM : 55.57 (-0.13%)
RFEU : 60.64 (-0.15%)
FCVT : 34.26 (+0.06%)
FDIV : 49.00 (+0.63%)
FTSL : 46.12 (-0.13%)
FTSM : 59.43 (+0.03%)
HYLS : 42.31 (-0.05%)
Wave of Solid Q3 Earnings Push Pharma ETFs Higher

The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.

PJP : 75.24 (-1.16%)
IHE : 188.34 (-1.57%)
XPH : 43.70 (-1.53%)
PPH : 75.83 (-0.72%)
FTXH : 26.38 (-0.99%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.67 (-0.10%)
FEMB : 27.16 (+0.07%)
FMB : 51.65 (-0.36%)
FMHI : 49.17 (+0.04%)
RFDI : 57.28 (-0.44%)
RFEM : 55.57 (-0.13%)
RFEU : 60.64 (-0.15%)
FCVT : 34.26 (+0.06%)
FDIV : 49.00 (+0.63%)
FTSL : 46.12 (-0.13%)
HYLS : 42.31 (-0.05%)
LMBS : 48.44 (-0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks...

See More

Key Turning Points

3rd Resistance Point 26.98
2nd Resistance Point 26.86
1st Resistance Point 26.62
Last Price 26.38
1st Support Level 26.25
2nd Support Level 26.12
3rd Support Level 25.88

See More

52-Week High 28.44
Fibonacci 61.8% 26.71
Last Price 26.38
Fibonacci 50% 26.18
Fibonacci 38.2% 25.65
52-Week Low 23.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar